Market sentiment signals for Ligand Pharmaceuticals (LGND): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
12 analysts
Options Flow (P/C)
—
Avg Consensus PT
$302
+1.3%
Highest Price Target
$397
+33.4%
Lowest Price Target
$140
-53.0%
Short Interest
16.1%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Barclays | Glen Santangelo— | +15.9% | $345 | Initiate | Overweight |
| Sep 24, 2026 | HC Wainwright & Co. | Joseph Pantginis— | +20.3% | $358 → $358 | Maintained | Buy |
